Follow up on Purdue's approval of Hysingla - Relmada Therapeutics Print E-mail
Thursday, 20 November 2014 20:19
New York-based Relmada Therapeutics (RLMD) has reinvented four proven and promising drug candidates with novel delivery systems to create new drugs for new indications.
Read more...
 
RELMADA THERAPEUTICS APPOINTS MICHAEL BECKER AS SENIOR VICE PRESIDENT OF FINANCE AND CORPORATE DEVELOPMENT Print E-mail
Tuesday, 04 November 2014 19:51
New York, NY--Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Michael D. Becker as senior vice president of finance and corporate development, effective immediately.
Read more...
 
LA BioMed Receives Phase II Grand Challenges Explorations Funding Print E-mail
Monday, 03 November 2014 20:41
LOS ANGELES - Los Angeles Biomedical Research Institute ( LA BioMed) announced today that it will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges.
Read more...
 
Newsmakers: Isis Pharmaceuticals, Alliqua BioMedical, Health Net, Mesa Laboratories, ANI Pharmaceuticals Print E-mail
Monday, 03 November 2014 15:04
Stocks edged higher in afternoon trading Monday, with major indexes pushing deeper into record territory ahead of fresh economic updates this week.
Read more...
 
Movers: Johnson & Johnson, Perrigo Company, AstraZeneca, Acadia Healthcare Company, Charles River Laboratories Print E-mail
Thursday, 30 October 2014 14:08
U.S. stocks extended gains in afternoon trading, as a strong earnings report from Visa Inc. spurred a sharp advance in the Dow industrials.
Read more...
 
Newsmakers: Gilead, Amedisys, Compugen, iCAD, Cara Therapeutics Print E-mail
Wednesday, 29 October 2014 14:12
U.S. stocks dipped and bonds slid after the Federal Reserve offered a brighter assessment of the U.S. job market, a shift that investors reckoned could bring forward the timing of interest-rate increases.
Read more...
 
Movers: Columbia Laboratories, Neurometrix, Cynosure, Receptos, Bristol-Myers Print E-mail
Tuesday, 28 October 2014 14:32
U.S. stocks climbed in afternoon trading on Tuesday, following stronger-than-expected earnings and an upbeat consumer confidence reading.
Read more...
 
Case Western Reserve University to Study Pluristem's PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases Print E-mail
Monday, 27 October 2014 15:59
HAIFA, Israel--Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-derived cell therapy products, announced today that researchers at Case Western Reserve University will conduct a preclinical study of the Company's PLacental eXpanded (PLX)-RAD cells.
Read more...
 
Actinium Announces Collaboration with Albert Einstein College of Medicine on New Actinium Program Print E-mail
Monday, 27 October 2014 15:23
  New York, NY--Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, and Albert Einstein College of Medicine of Yeshiva University, a research-intensive medical school in Bronx, NY, started development of an antibody construct labeled with actinium 225 using a novel technology that potentially allows for the expansion of use of the Company‚Äôs proprietary platform and enables further manufacturing improvements of alpha therapy technology based drug candidates.
Read more...
 
Movers: IsoRay, IDEXX Laboratories, Shire plc, IGI Laboratories, Vitae Pharmaceuticals Print E-mail
Friday, 24 October 2014 14:35
U.S. stocks were on pace to close out their best week in nearly two years on Friday, helped by earnings from Microsoft and Procter & Gamble and as concerns eased over the possible spread of Ebola.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 7 of 12

Newsletter